Both pathologies involving the mitral valve have genetic causes: in mitral valve prolapse, most, if not all changes, revolve around the activity of TGF-β, whereas the mutations responsible for the modifications in hypertrophic cardiomyopathy are in genes that mostly codify sarcomeric proteins. This evidence concerns the gene TGFB1 and hypertrophic cardiomyopathy.